Identification of novel neuroprotective agents using pharmacophore modeling

Chemistry and Biodiversity

Volumn 2, Issue 11, 2005, Pages 1564-1570

  Faden, Alan I ^a   Movsesyan, Vilen A ^a   Fang, Xueliang ^b   Wang, Shaomeng ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPROTECTIVE AGENT; PROTIRELIN DERIVATIVE; TETRAHYDROSPIRO[CYCLOHEXANE 1,3'(4'H) PYROLO[1,2ALPHA]PYRAZINE] 1',4'(2') DIONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL DEATH; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; IN VITRO STUDY; NEUROPROTECTION; NONHUMAN; PHARMACOPHORE; RAT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; MODELS, MOLECULAR; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 28844491612     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200590127     Document Type: Article

References (29)

1. S. S. Panter, A. I. Faden, in 'Principles and Practice of Restorative Neurology', Butterworth's, New York, 1992, p. 32.
2. T. K. McIntosh, Cerebrovasc. Brain Metab. Rev. 1994, 6, 109.
3. A. G. Yakovlev, A. I. Faden, NeuroRX. 2004, 1, 5.
4. D. E. Bredesen, The Neuroscientist 1996, 2, 181.
5. A. I. Faden, Pharmacol. Toxicol. 1996, 78, 12.
6. A. I. Maas, Expert Opin. Investig. Drugs 2001, 10, 753.
7. A. I. Faden, Curr. Opin. Neurol. 2002, 15, 707.
8. A. I. Faden, T. P. Jacobs, J. W. Holaday, New Engl. J. Med. 1981, 305, 1063.
9. S. Manaka, K. Sano, Neurosci. Lett. 1978, 8, 255.
10. N. Fukuda, Y. Saji, Y. Nagawa, Nippon Yakurigaku Zasshi 1979, 75, 321.
11. M. Arias, Surg. Neurol. 1987, 28, 335.
12. K. Takami, T. Hashimoto, A. Shino, N. Fukuda, Jpn. J. Pharmacol. 1991, 57, 405.
13. G. L. Wang, C. Zhu, Chin. Med. J. (Engl.) 1991, 104, 939.
14. S. Ceylan, K. Ilbay, S. Baykal, U. Şener, M. Özmenoglu, M. Kalelioǧlu, F. Aktürk, S. S. Komşuoǧlu, A. Özoran, Res. Exp. Med. 1992, 192, 23.
15. H. Akdemir, H. Paşaoglu, F. Arman, B. Çoksevim, A. Paşaoǧlu, Res. Exp. Med. 1993, 193, 297.
16. D. L. Behrmann, J. C. Bresnahan, M. S. Beattie, Exp. Neurol. 1993, 119, 258.
17. D. L. Behrmann, J. C. Bresnahan, M. S. Beattie, Exp. Neurol. 1994, 126, 61.
18. M. A. Puniak, G. M. Freeman, C. A. Agresta, L. Van Newkirk, C. A. Barone, S. K. Salzman, J. Neurotrauma 1991, 8, 193.
19. S. Ceylan, M. Kalelioǧlu, G. Aktürk, F. Aktürk, Res. Exp. Med. 1990, 190, 111.
20. A. I. Faden, T. P. Jacobs, M. T. Smith, Neurology 1984, 34, 1280.
21. L. H. Pitts, A. Ross, G. A. Chase, A. I. Faden, J. Neurotrauma 1995, 12, 235.
22. R. M. Bassiri, R. D. Utiger, J. Clin. Invest. 1973, 52, 1616.
23. A. I. Faden, G. B. Fox, L. Fan, G. L. Araldi, L. Qiao, S. Wang, A. P. Kozikowski, Am. J. Physiol. 1999, 277 R1196.
24. K. R. Prakash, Y. Tang, A. P. Kozikowski, J. L. Flippen-Anderson, S. M. Knoblach, A. I. Faden, Bioorg. Med. Chem. 2002, 10, 3043.
25. A. I. Faden, S. M. Knoblach, I. Cernak, L. Fan, R. Vink, G. L. Araldi, S. T. Fricke, B. Roth, A. P. Kozikowski, J. Cereb. Blood Flow Metab. 2003, 23, 342.
26. A. I. Faden, G. B. Fox, X. Di, S. M. Knoblach, I. Cernak, P. Mullins, M. Nikolaeva, A. P. Kozikowski, J. Cereb. Blood Flow Metab. 2003, 23, 355.
27. S. Wang, S. Sakamuri, I. J. Enyedy, A. P. Kozikowski, O. Deschaux, B. C. Bandyopadbyay, S. R. Tella, W. A. Zaman, K. M. Johnson, J. Med. Chem. 2000, 43, 351.
28. X. Fang, S. Wang, J. Chem. Inf. Comput. Sci. 2002, 42, 192.
29. A. G. Mukhin, S. A. Ivanova, S. M. Knoblach, A. I. Faden, J. Neurotrauma 1997, 14, 651.